Eric E. Easom

978 citations

16 papers · 499 indexed · h-index 14

Impact in

Parasitology top 5%
- Parasitic Infections and Diagnostics
Organic Chemistry top 10%
- Organoboron and organosilicon chemistry
- Synthesis and Biological Evaluation

Papers in ⓘ

Parasitology 4
Infectious Diseases 10
- HIV/AIDS drug development and treatment 6

Co-authors: Jacob J. Plattner (13 shared papers)Yvonne R. Freund (11 shared papers)Yong-Kang Zhang (8 shared papers)Philip J. Rosenthal (6 shared papers)Robert T. Jacobs (7 shared papers)Min Ge (5 shared papers)Francisco‐Javier Gamo (4 shared papers)David Waterson (3 shared papers)
Journals: Bioorganic & Medicinal Chemistry Letters (5 papers)Journal of Medicinal Chemistry (2 papers)Tetrahedron Letters (1 paper)mBio (1 paper)Nature Communications (1 paper)
Partner nations: United States China Switzerland

In The Last Decade

Eric E. Easom

16 papers receiving 481 citations

Peers

Countries citing papers authored by Eric E. Easom

Since Specialization

Citations

This map shows the geographic impact of Eric E. Easom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric E. Easom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric E. Easom more than expected).

Fields of papers citing papers by Eric E. Easom

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric E. Easom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric E. Easom. The network helps show where Eric E. Easom may publish in the future.

Co-authors

The 25 scholars most cited alongside Eric E. Easom, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eric E. Easom Line = papers co-authored together Eric E. Easom links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work
1	Synthesis and structure–activity relationships of novel benzoxaboroles as a new class of antimalarial agents Bioorganic & Medicinal Chemistry Letters ·Yong-Kang Zhang, Jacob J. Plattner, Yvonne R. Freund, Eric E. Easom, Yasheen Zhou, Jiří Gut, Philip J. Rosenthal, David Waterson, Francisco‐Javier Gamo, Íñigo Angulo‐Barturen, Min Ge, Zhiya Li, Lingchao Li, Yong Jian, Han Cui, Hailong Wang, Jian Yuan Yang	2010	62
2	Targeting Toxoplasma gondii CPSF 3 as a new approach to control toxoplasmosis EMBO Molecular Medicine ·Andrés Palencia, Alexandre Bougdour, Marie‐Pierre Brenier‐Pinchart, Bastien Touquet, Rose‐Laurence Bertini, Cristina Sensi, Gabrielle Gay, Julien Vollaire, Véronique Josserand, Eric E. Easom, Yvonne R. Freund, Hervé Pelloux, Philip J. Rosenthal, S. Cusack, Mohamed‐Ali Hakimi	2017	59
3	Benzoxaborole Antimalarial Agents. Part 5. Lead Optimization of Novel Amide Pyrazinyloxy Benzoxaboroles and Identification of a Preclinical Candidate Journal of Medicinal Chemistry ·Yong-Kang Zhang, Jacob J. Plattner, Eric E. Easom, Robert T. Jacobs, Denghui Guo, Yvonne R. Freund, Pamela Berry, Vic Ciaravino, John C. L. Erve, Philip J. Rosenthal, Brice Campo, Francisco‐Javier Gamo, Laura M. Sanz, Jianxin Cao	2017	53
4	Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosis Nature Communications ·Christopher S. Lunde, Erin E. Stebbins, Rajiv S. Jumani, Mahmudul Hasan, Peter G. Miller, John Barlow, Yvonne R. Freund, Pamela Berry, Rianna Stefanakis, Jiří Gut, Philip J. Rosenthal, Melissa S. Love, Case W. McNamara, Eric E. Easom, Jacob J. Plattner, Robert T. Jacobs, Christopher D. Huston	2019	44
5	Benzoxaborole antimalarial agents. Part 2: Discovery of fluoro-substituted 7-(2-carboxyethyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles Bioorganic & Medicinal Chemistry Letters ·Yong-Kang Zhang, Jacob J. Plattner, Yvonne R. Freund, Eric E. Easom, Yasheen Zhou, Long Ye, Huchen Zhou, David Waterson, Francisco‐Javier Gamo, Laura M. Sanz, Min Ge, Zhiya Li, Lingchao Li, Hailong Wang, Han Cui	2011	43
6	Discovery of an orally active benzoxaborole prodrug effective in the treatment of Chagas disease in non-human primates Nature Microbiology ·Ángel M. Padilla, Wei Wang, Tsutomu Akama, David S. Carter, Eric E. Easom, Yvonne R. Freund, Jason Halladay, Yang Liu, Sarah A. Hamer, Carolyn L. Hodo, Gregory K. Wilkerson, Dylan Orr, Brooke E. White, Arlene J. George, Huifeng Shen, Yiru Jin, Michael Zhuo Wang, Susanna Tse, Robert T. Jacobs, Rick L. Tarleton	2022	39
7	Identification of a 4-fluorobenzyl l-valinate amide benzoxaborole (AN11736) as a potential development candidate for the treatment of Animal African Trypanosomiasis (AAT) Bioorganic & Medicinal Chemistry Letters ·Tsutomu Akama, Yong-Kang Zhang, Yvonne R. Freund, Pamela Berry, Joanne Lee, Eric E. Easom, Robert T. Jacobs, Jacob J. Plattner, Michael J. Witty, Rosemary Peter, T.G. Rowan, Kirsten Gillingwater, Reto Brun, Bakela Nare, Luke Mercer, Musheng Xu, Jiangong Wang, Hao Liang	2017	33
8	Benzoxaborole Antimalarial Agents. Part 4. Discovery of Potent 6-(2-(Alkoxycarbonyl)pyrazinyl-5-oxy)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles Journal of Medicinal Chemistry ·Yong-Kang Zhang, Jacob J. Plattner, Eric E. Easom, Robert T. Jacobs, Denghui Guo, Virginia Sanders, Yvonne R. Freund, Brice Campo, Philip J. Rosenthal, Wei Bu, Francisco‐Javier Gamo, Laura M. Sanz, Min Ge, Liang Li, Jie Ding, Yin Yang	2015	29
9	An efficient synthesis for a new class antimalarial agent, 7-(2-carboxyethyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaborole Tetrahedron Letters ·Yong-Kang Zhang, Jacob J. Plattner, Eric E. Easom, David Waterson, Min Ge, Zhiya Li, Lingchao Li, Yong Jian	2011	26
10	Discovery of an orally bioavailable isoxazoline benzoxaborole (AN8030) as a long acting animal ectoparasiticide Bioorganic & Medicinal Chemistry Letters ·Yong-Kang Zhang, Jacob J. Plattner, Eric E. Easom, Yasheen Zhou, Tsutomu Akama, Wei Bu, W. Hunter White, Jean Defauw, Joseph R. Winkle, Terry W. Balko, Shenghai Guo, Jian Xue, Jianxin Cao, Wuxin Zou	2015	26
11	Plasmodium falciparum Resistance to a Lead Benzoxaborole Due to Blocked Compound Activation and Altered Ubiquitination or Sumoylation mBio ·Kirthana M. V. Sindhe, Wesley Wu, Jenny Legac, Yong-Kang Zhang, Eric E. Easom, Roland A. Cooper, Jacob J. Plattner, Yvonne R. Freund, Joseph L. DeRisi, Philip J. Rosenthal	2020	21
12	Optimization of isoxazoline amide benzoxaboroles for identification of a development candidate as an oral long acting animal ectoparasiticide Bioorganic & Medicinal Chemistry Letters ·Yong-Kang Zhang, Jacob J. Plattner, Eric E. Easom, Tsutomu Akama, Yasheen Zhou, W. Hunter White, Jean Defauw, Joseph R. Winkle, Terry W. Balko, Jianxin Cao, Zhixin Ge, Jianzhang Yang	2016	19
13	Macrofilaricidal Benzimidazole–Benzoxaborole Hybrids as an Approach to the Treatment of River Blindness: Part 2. Ketone Linked Analogs ACS Infectious Diseases ·David S. Carter, Robert T. Jacobs, Yvonne R. Freund, Pamela Berry, Tsutomu Akama, Eric E. Easom, Christopher S. Lunde, Fernando Rock, Rianna Stefanakis, James H. McKerrow, Chelsea Fischer, Christina A. Bulman, Kee Chong Lim, Brian M. Suzuki, Nancy Tricoche, Judy A. Sakanari, Sara Lustigman, Jacob J. Plattner	2019	16
14	Benzoxaborole antimalarial agents. Part 3: design and syntheses of (carboxy‐¹³C‐3,3‐²H₂)‐labeled and (3‐¹⁴C)‐labeled 7‐(2‐carboxyethyl)‐1,3‐dihydro‐1‐hydroxy‐2,1‐benzoxaboroles Journal of Labelled Compounds and Radiopharmaceuticals ·Yong‐Kang Zhang, Jacob J. Plattner, Eric E. Easom, Liang Liu, Daniel M. Retz, Min Ge, Hui‐Hong Zhou	2012	13
15	In vivo efficacy of the boron-pleuromutilin AN11251 against Wolbachia of the rodent filarial nematode Litomosoides sigmodontis PLoS neglected tropical diseases ·Alexandra Ehrens, Christopher S. Lunde, Robert T. Jacobs, Dominique Struever, Marianne Koschel, Stefan J. Frohberger, Franziska Lenz, Martina Fendler, Joseph D. Turner, Stephen A. Ward, Mark J. Taylor, Yvonne R. Freund, Rianna Stefanakis, Eric E. Easom, Xianfeng Li, Jacob J. Plattner, Achim Hoerauf, Marc P. Hübner	2020	12
16	1727. Phase 1b Dose-ranging Study Demonstrates Tolerability and Pharmacokinetics (PK) of Oral Epetraborole at the Predicted Therapeutic Dosage for Mycobacterium avium Complex (MAC) Lung Disease Open Forum Infectious Diseases ·Paul B. Eckburg, Dave Clarke, Jennifer Long, Sanjay Chanda, Kevin M. Krause, Eric E. Easom, George H. Talbot, Christopher M. Rubino, Angela Molga	2022	4

About Eric E. Easom

Eric E. Easom is a scholar working on Parasitology, Infectious Diseases, Epidemiology, Insect Science and Microbiology, having authored 16 papers that have together received 499 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (6 papers), Malaria Research and Control (4 papers), Herpesvirus Infections and Treatments (3 papers), Organoboron and organosilicon chemistry (3 papers), Trypanosoma species research and implications (3 papers), Insect and Pesticide Research (2 papers), Biochemical and Molecular Research (2 papers) and Synthesis and bioactivity of alkaloids (2 papers). The work is most often cited by research in Parasitology (88 citations), Organic Chemistry (194 citations), Infectious Diseases (93 citations), Public Health, Environmental and Occupational Health (124 citations) and Epidemiology (105 citations). Eric E. Easom has collaborated with scholars based in United States, China and Switzerland. Frequent co-authors include Jacob J. Plattner, Yvonne R. Freund, Yong-Kang Zhang, Philip J. Rosenthal, Robert T. Jacobs, Min Ge, Francisco‐Javier Gamo, David Waterson, Yasheen Zhou and Lingchao Li. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Tetrahedron Letters, mBio and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact